With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Ectopic Neuroligin Signaling in Pediatric Glioblastoma||University of Utah / Alex Shcheglovitov, PhD||Innovation Grants||2023||Utah|
|Stapled Oncolytic Peptides for Treatment-Resistant Pediatric Leukemias||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD||Innovation Grants||2023||Massachusetts|
|Desmoplastic Small Round Cell Tumors: Investigation of its Pathogenesis and Development of Novel Therapies||Memorial Sloan-Kettering Cancer Center / Andrea Ventura, MD, PhD||Innovation Grants||2023||New York|
|In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies||Baylor College of Medicine / Masataka Suzuki, PhD||Innovation Grants||2023||Texas|
|Pre-Targeted Radioimmunotherapy for Desmoplastic Small Round Cell Tumors||Memorial Sloan-Kettering Cancer Center / Madelyn Espinosa-Cotton, PhD||Young Investigator Grants||2023||New York|
|Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network||Boston Children's Hospital / Richard Voit, MD/PhD||Young Investigator Grants||2023||Massachusetts|
|Elucidating the Roles of Aneuploidy in Down Syndrome-Associated Leukemia||Boston Children's Hospital / Chun-Chin Chen, PhD||Young Investigator Grants||2023||Massachusetts|
|Targeting Oncogenic N-MYC Complexes in High-Risk Neuroblastoma||The Regents of the University of California San Francisco / Bo Qiu, MD/PhD||Young Investigator Grants||2023||California|
|Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS||St. Jude Children's Research Hospital / Dirk Loeffler, PhD||RUNX1 Early Career Investigator Grants||2023||Tennessee|
|Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells||The Regents of the University of Minnesota / Timothy Hallstrom, PhD||Innovation Grants||2023||Minnesota|